Bamat MK - Search Results

1

A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization.

Laurie SA, Bell JC, Atkins HL, Roach J, Bamat MK, O'Neil JD, Roberts MS, Groene WS, Lorence RM. Laurie SA, et al. Among authors: bamat mk. Clin Cancer Res. 2006 Apr 15;12(8):2555-62. doi: 10.1158/1078-0432.CCR-05-2038. Clin Cancer Res. 2006. PMID: 16638865 Clinical Trial.

2

Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers.

Pecora AL, Rizvi N, Cohen GI, Meropol NJ, Sterman D, Marshall JL, Goldberg S, Gross P, O'Neil JD, Groene WS, Roberts MS, Rabin H, Bamat MK, Lorence RM. Pecora AL, et al. Among authors: bamat mk. J Clin Oncol. 2002 May 1;20(9):2251-66. doi: 10.1200/JCO.2002.08.042. J Clin Oncol. 2002. PMID: 11980996 Clinical Trial.

3

An optimized clinical regimen for the oncolytic virus PV701.

Hotte SJ, Lorence RM, Hirte HW, Polawski SR, Bamat MK, O'Neil JD, Roberts MS, Groene WS, Major PP. Hotte SJ, et al. Among authors: bamat mk. Clin Cancer Res. 2007 Feb 1;13(3):977-85. doi: 10.1158/1078-0432.CCR-06-1817. Clin Cancer Res. 2007. PMID: 17289893 Clinical Trial.

4

Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus.

Lorence RM, Roberts MS, O'Neil JD, Groene WS, Miller JA, Mueller SN, Bamat MK. Lorence RM, et al. Among authors: bamat mk. Curr Cancer Drug Targets. 2007 Mar;7(2):157-67. doi: 10.2174/156800907780058853. Curr Cancer Drug Targets. 2007. PMID: 17346107 Review.

5

Overview of phase I studies of intravenous administration of PV701, an oncolytic virus.

Lorence RM, Pecora AL, Major PP, Hotte SJ, Laurie SA, Roberts MS, Groene WS, Bamat MK. Lorence RM, et al. Among authors: bamat mk. Curr Opin Mol Ther. 2003 Dec;5(6):618-24. Curr Opin Mol Ther. 2003. PMID: 14755888 Review.

6

Naturally oncolytic viruses.

Roberts MS, Lorence RM, Groene WS, Bamat MK. Roberts MS, et al. Among authors: bamat mk. Curr Opin Mol Ther. 2006 Aug;8(4):314-21. Curr Opin Mol Ther. 2006. PMID: 16955694 Review.

7

Naturally occurring viruses for the treatment of cancer.

Roberts MS, Groene WS, Lorence RM, Bamat MK. Roberts MS, et al. Among authors: bamat mk. Discov Med. 2006 Dec;6(36):217-22. Discov Med. 2006. PMID: 17250786 Free article.

8

Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity.

Ma WW, Saif MW, El-Rayes BF, Fakih MG, Cartwright TH, Posey JA, King TR, von Borstel RW, Bamat MK. Ma WW, et al. Among authors: bamat mk. Cancer. 2017 Jan 1;123(2):345-356. doi: 10.1002/cncr.30321. Epub 2016 Sep 13. Cancer. 2017. PMID: 27622829 Free PMC article.

9

Prompt treatment with uridine triacetate improves survival and reduces toxicity due to fluorouracil and capecitabine overdose or dihydropyrimidine dehydrogenase deficiency.

Garcia RAG, Saydoff JA, Bamat MK, von Borstel RW. Garcia RAG, et al. Among authors: bamat mk. Toxicol Appl Pharmacol. 2018 Aug 15;353:67-73. doi: 10.1016/j.taap.2018.06.012. Epub 2018 Jun 13. Toxicol Appl Pharmacol. 2018. PMID: 29908244

10

Acceleration of wound healing with topically applied deoxyribonucleosides.

Chen EA, Zhao L, Bamat M, von Borstel R, Mustoe T. Chen EA, et al. Arch Surg. 1999 May;134(5):520-5. doi: 10.1001/archsurg.134.5.520. Arch Surg. 1999. PMID: 10323424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters